Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7539236rdf:typepubmed:Citationlld:pubmed
pubmed-article:7539236lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:7539236lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:7539236lifeskim:mentionsumls-concept:C0149925lld:lifeskim
pubmed-article:7539236lifeskim:mentionsumls-concept:C0220650lld:lifeskim
pubmed-article:7539236lifeskim:mentionsumls-concept:C0039512lld:lifeskim
pubmed-article:7539236lifeskim:mentionsumls-concept:C0079083lld:lifeskim
pubmed-article:7539236lifeskim:mentionsumls-concept:C1518422lld:lifeskim
pubmed-article:7539236pubmed:issue2lld:pubmed
pubmed-article:7539236pubmed:dateCreated1995-6-23lld:pubmed
pubmed-article:7539236pubmed:abstractTextThe role of chemotherapy alone or added to radiation treatment for the palliation of multiple, unresectable brain metastases from non small cell lung cancer (NSCLC), is not yet well defined. Carboplatin and teniposide, however, are an interesting combination in this setting since they are active in NSCLC and because of encouraging results against brain metastases in other tumor types.lld:pubmed
pubmed-article:7539236pubmed:languageenglld:pubmed
pubmed-article:7539236pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7539236pubmed:citationSubsetIMlld:pubmed
pubmed-article:7539236pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7539236pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7539236pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7539236pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7539236pubmed:statusMEDLINElld:pubmed
pubmed-article:7539236pubmed:issn0250-7005lld:pubmed
pubmed-article:7539236pubmed:authorpubmed-author:PronzatoPPlld:pubmed
pubmed-article:7539236pubmed:authorpubmed-author:NerbLLlld:pubmed
pubmed-article:7539236pubmed:authorpubmed-author:BertelliGGlld:pubmed
pubmed-article:7539236pubmed:authorpubmed-author:VanoliMMlld:pubmed
pubmed-article:7539236pubmed:authorpubmed-author:RoveriDDlld:pubmed
pubmed-article:7539236pubmed:authorpubmed-author:ViganiAAlld:pubmed
pubmed-article:7539236pubmed:authorpubmed-author:BrunaFFlld:pubmed
pubmed-article:7539236pubmed:authorpubmed-author:VairoPPlld:pubmed
pubmed-article:7539236pubmed:authorpubmed-author:LosardoPPlld:pubmed
pubmed-article:7539236pubmed:authorpubmed-author:TrabucchiAAlld:pubmed
pubmed-article:7539236pubmed:issnTypePrintlld:pubmed
pubmed-article:7539236pubmed:volume15lld:pubmed
pubmed-article:7539236pubmed:ownerNLMlld:pubmed
pubmed-article:7539236pubmed:authorsCompleteYlld:pubmed
pubmed-article:7539236pubmed:pagination517-9lld:pubmed
pubmed-article:7539236pubmed:dateRevised2010-3-24lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:meshHeadingpubmed-meshheading:7539236-...lld:pubmed
pubmed-article:7539236pubmed:articleTitleRadiotherapy plus carboplatin and teniposide in patients with brain metastases from non small cell lung cancer.lld:pubmed
pubmed-article:7539236pubmed:affiliationU.O. Oncologia Medica, Ospedale S. Andrea, La Spezia, Italy.lld:pubmed
pubmed-article:7539236pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7539236pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:7539236pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed